← Back to Search

Education and Screening for Hepatitis C and Colorectal Cancer (MATCHES Trial)

N/A

Recruiting

Led By Shannon Christy, PhD

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Participants must be able to read, write, and understand English or Spanish

Participants must be 45-75 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 41 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to encourage patients between the ages of 45-75 at community health centers to get screened for both Hepatitis C Virus (HCV) and Colorectal Cancer (CRC) at

Who is the study for?

The MATCHES trial is for English or Spanish-speaking individuals aged 45-75 who have never been screened for Hepatitis C Virus (HCV), are at average risk for colorectal cancer (CRC), and aren't up to date with CRC screening. They must be willing to complete surveys, interviews via phone or video call, and provide informed consent. Those with a personal history of CRC, current symptoms, or not receiving care at participating clinics are excluded.

What is being tested?

MATCHES is testing an educational intervention designed to encourage simultaneous screening for HCV and CRC in patients attending Federally Qualified Health Centers (FQHCs). The study involves providing materials, completing surveys, and possibly participating in remote interviews.

What are the potential side effects?

Since this trial focuses on education and screening rather than medication or invasive procedures, there are no direct side effects from the interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can read, write, and understand English or Spanish.

Select...

I am between 45 and 75 years old.

Select...

I am not up to date with my colorectal cancer screenings.

Select...

I have never had colorectal cancer and currently show no symptoms of it.

Select...

I do not have symptoms of hepatitis C.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 41 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 41 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 41 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Screening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC)

Secondary study objectives

Completion of repeat CRC Screening

Screening Completion for Colorectal Cancer (CRC)

Screening Completion for Hepatitis C Virus (HCV)

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening (MATCHES)Experimental Treatment1 Intervention

The MATCHES intervention includes three patient-level intervention strategies that will be rolled out in two waves. Patient-level strategies are: 1) a combined education booklet with information about CRC/CRC screening and HCV infections/liver cancer/HCV screening in English or Spanish, 2) access to free stool-based CRC screening, and 3) access to free HCV antibody testing.

0 / 5Eligibility criteria met